7.4
14.3*
0
5
10
15
Placebo
Rimonabant
20 mg
11.5
-6.1*
-10
-5
0
5
10
Placebo
Rimonabant 20 mg
*P<0.001 vs placebo
Changes in HDL-C and TG at 1 year:
patients on concomitant statin therapy
Baseline
1.18 (0.31)
1.27 (0.33) mmol/L
Mean (SD)
15
Baseline
1.83 (1.02)
1.84 (1.05) mmol/L
Mean (SD)
Pooled RIO studies in statin treated patients n=681
Després JP et al, 2006
Changes in HDL-C and triglycerides at 1 year: patients on concomitant statin therapy
In the presence or in absence of statin therapy, rimonabant 20 mg had the same benefits on HDL and triglycerides.
Subanalysis preformed in the pooled RIO studies of all patients on statin treatment included in the four studies.